A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-69
SponsorMayo Clinic
About this trial
The purpose of this research is to gather information on the safety and effectiveness of Endoscopic Sleeve Gastroplasty (ESG) for weight loss in a population of obese UC patients undergoing colectomy with eventual IPAA.
Eligibility criteria
Qualifiers
BMI 30-50 kg/m2 for at least 6 months prior to ESG
Diagnosis of UC with plans to undergo or who have already undergone colectomy as part of a plan to pursue eventual 3-stage ileal pouch anal anastomosis (IPAA)
Willing to adhere to the diet and behavior modifications required for ESG
Able to follow the visit schedule
Disqualifiers
Prior gastric or bariatric surgery or other alteration to upper gastrointestinal anatomy which would preclude safe or technical performance of ESG
Current or recent (last six months) gastric or duodenal ulceration
Esophageal or gastric varices
Significant motility disorder of the esophagus or stomach
Trial design
Treatments tested in this trial
- Apollo Endoscopic Suture System
- Lifestyle Intervention
Treatment groups
12 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov